Skip to main content
Year archive

Orexo — 2022 filings

All 16 regulatory filings released by Orexo (ORX) in 2022, sourced directly from the official regulator.

16 Filings
2022 Period
2022 filings (16)
Filing Released Lang
Interim / Quarterly Report 2022
Interim / Quarterly Report Q3 2022
2022-11-03 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q3 2022
2022-11-03 English
Orexo rapporterar positiva data från klinisk fas 1-studie för OX640 - ett nasalt akutläkemedel med adrenalin vid allergiska reaktioner
Earnings Release FY 2022
2022-10-11 Swedish
Orexo announces positive data from phase 1 clinical study for OX640 - a nasal epinephrine rescue medication for allergic reactions
Earnings Release FY 2022
2022-10-11 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Q2 2022
2022-07-14 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q2 2022
2022-07-14 English
Orexos digitala terapi deprexis® subventionerad av amerikanska Veterans Affairs Federal Supply Schedule
Regulatory Filings
2022-07-13 Swedish
Orexo's digital therapy deprexis® reimbursed under the US Veterans Affairs Federal Supply Schedule
Regulatory Filings
2022-07-13 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Q1 2022
2022-04-28 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q1 2022
2022-04-28 English
Report from Orexo AB’s annual general meeting
AGM Information
2022-04-21 English
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-03-31 Swedish
Kallelse till årsstämma i Orexo
AGM Information
2022-03-21 Swedish
Notice of Annual General Meeting of Orexo
AGM Information
2022-03-21 English
Earnings Release 2021
Earnings Release Q4 2021
2022-01-27 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q4 2021
2022-01-27 English